VIRGINIA KAKLAMANI
@vkaklamani
Oncologist and tennis player
ID: 1325138776121888768
07-11-2020 18:11:32
262 Tweet
1,1K Followers
145 Following
Join Aditya Bardia, MD VIRGINIA KAKLAMANI and I 6/1 for dinner and lively discussion on novel therapies for HR+ MBC. Next-Generation Therapeutics for HR+/HER2- Breast Cancer: Spotlight on SERDs | CCO clinicaloptions.com/events/serds-f…
Significant OS benefit of pembro. Now questions are: do we need that much chemo; do we need adj pembro after pCR; is there signature of response; what do we do with T1c? Great discussion below. SABCS Sara Tolaney Kate Lathrop #sabcssnippets
On a day like today Chicago for me is the most beautiful city in the US. Looking forward to #asco24 UT Health San Antonio MD Anderson
Great review by Ruth O'Regan on ET in MBC. Inavo in ET resistance shows benefit; no role for chemo in 1st line setting; sequencing cdks can produce benefit but based on other available options may have to be selective in its use. #asco24
Wonderful to see our junior colleagues have oral presentations. Sara Tolaney this doesn’t go unnoticed. #ASCO24
Honored to participate in an ASCO OncLive.com Peer Direct panel on Advances in HR+ HER2- mBC with my esteemed colleagues Drs Hurvitz, Pegram and VIRGINIA KAKLAMANI. Go to OncLive.com to see our finished production. Thank you to organizers for the opportunity!
Fellow graduation last night. What an amazing group of physicians who will help change the world. So proud of them. Kate Lathrop Marcela Mazo UT Health San Antonio MD Anderson
#sabcssnippets on highlights from #ASCO24 Thank you William Gradishar, MD Heather McArthur, MD, MPH and Aditya Bardia, MD for contributing your thoughts SABCS UT Health San Antonio MD Anderson youtu.be/7qGniRrl2BE
Had the honor to know him during my training. Worked in the lab next door. Was always a treat to talk science with him. #bcsm Lurie Cancer Center mdanderson.org/newsroom/md-an…
With Dr Seema Khan comparing the nccn and Chinese guidelines in breast cancer care. Always humbling to hear views from our Chinese colleagues #bcsm UT Health San Antonio MD Anderson Lurie Cancer Center
Just published online. Very proud of this work. Aditya Bardia, MD UT Health San Antonio MD Anderson aacrjournals.org/clincancerres/…
Podcasts on role of GnRH agonists in early stage BC Ann Partridge MD, MPH medlearninggroup.com/cme-programmin… #bcsm
New National Comprehensive Cancer Network (NCCN) guidelines for Breast/Ovarian/Pancreatic Cancer Genetics posted at nccn.org/professionals/… New recommendation that #PancreaticCancer screening be “considered” for all BRCA2 and ATM pathogenic variant carriers by age 50, even without known family history
Received this in the mail last week and I am thrilled to announce that #October15 is officially recognized as #Lobular #BreastCancer Awareness Day in the great state of #Texas! 🎉 We’re hosting a celebration MD Anderson Cancer Center to mark this incredible milestone. Special thanks to
Capitello 290 neg trial but was the primary endpoint really the right endpoint? Heather McArthur, MD, MPH ESMO - Eur. Oncology #bcsm